China Medical Technologies, Inc. (Nasdaq: CMED) today announced that the Company received approval for its Breast Cancer HER-2 FISH probe ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE